Journal Mobile Options
Table of Contents
Vol. 19, No. 1, 2001
Issue release date: 2001
Dig Dis 2001;19:24–31
(DOI:10.1159/000050650)

Experimental Animal Models in Pancreatic Carcinogenesis: Lessons for Human Pancreatic Cancer

Standop J. · Schneider M.B. · Ulrich A. · Pour P.M.
aUNMC Eppley Cancer Center, University of Nebraska Medical Center, Omaha, Nebr., USA; bDepartment of Surgery, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany; cDepartment of Visceral and Transplantation Surgery, Inselspital Bern, Switzerland; dDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebr., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The silent course of pancreatic cancer and its explosive fatal outcome have hindered studies of tumor histogenesis and the identification of early biochemical and genetic alterations that could help to diagnose the disease at a curable stage and develop therapeutic strategies. Experimental animal models provide important tools to assess risk factors, as well as preventive and therapeutic possibilities. Although several pancreatic cancer models presently exist, only models that closely resemble human tumors in morphological, clinical, and biological aspects present useful media for preclinical studies. Because an estimated 70% of human tumors are induced by carcinogens and because a significant association has been found between cigarette smoking and pancreatic cancer, chemically induced models are of particular value. Moreover, in such models the etiology, modifying factors, effects of diets, and naturally occurring products can be studied and early diagnostic, preventive, and therapeutic possibilities sought out. Many of the existing models are described in this review, and the advantages and shortcomings of each model and their clinical implications are discussed.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Wilson R, De Eds F, Cox A: The toxicity and carcinogenic activity of 2-acetaminofluorene. Cancer Res 1941;1:595.
  2. Longnecker DS: Animal model of human disease: Carcinoma of the pancreas in azaserine-treated rats. Am J Pathol 1981;105:94–96.

    External Resources

  3. Longnecker DS, Memoli V, Pettengill OS: Recent results in animal models of pancreatic carcinoma: Histogenesis of tumors: Yale J Biol Med 1992;65:457–464; Discussion 465–469.
  4. Rao MS: Animal models of exocrine pancreatic carcinogenesis. Cancer Metastasis Rev 1987;6:665–676.

    External Resources

  5. Makinen K, Loimas S, Nuutinen P, Eskelinen M, Alhava E: The growth pattern and microvasculature of pancreatic tumours induced with cultured carcinoma cells. Br J Cancer 2000;82:900–904.
  6. Pettengill OS, Faris RA, Bell RH Jr, Kuhlmann ET, Longnecker DS: Derivation of ductlike cell lines from a transplantable acinar cell carcinoma of the rat pancreas. Am J Pathol 1993;143:292–303.
  7. Hayashi Y, Hasegawa T: Experimental pancreatic tumor in rats after intravenous injection of 4-hydroxyaminoquinoline 1-oxide. Gann 1971;62:329–330.

    External Resources

  8. Reddy JK, Rao MS: Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator. J Natl Cancer Inst 1977;59:1645–1650.

    External Resources

  9. Reddy JK, Qureshi SA: Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats. Br J Cancer 1979;40:476–482.

    External Resources

  10. Longnecker DS, Curphey TJ, Lilja HS, French JI, Daniel DS: Carcinogenicity in rats of the nitrosourea amino acid N-delta-(N-methyl-N-nitrosocarbamoyl)-L-ornithine. J Environ Pathol Toxicol 1980;4:117–129.

    External Resources

  11. Longnecker D: Experimental pancreatic cancer: Role of species, sex and diet. Bull Cancer 1990;77:27–37.
  12. Vesselinovitch S, Rao K, Milhailovitch N: Enhances delivery of chemical carcinogens to the pancreas. Carcinogenesis Program, Second Annual Collaborative Conference. San Antonio, 1973, p 34.
  13. Pour PM, Wilson R: Experimental tumors of the pancreas; in Moossa AR (ed): Tumors of the Pancreas. Baltimore, Williams & Wilkins, 1980, pp 37–158.
  14. Rivera JA, Graeme-Cook F, Werner J, Z’Graggen K, Rustgi AK, Rattner DW, Warshaw AL, Fernandez-del Castillo C: A rat model of pancreatic ductal adenocarcinoma: Targeting chemical carcinogens. Surgery 1997;122:82–90.

    External Resources

  15. Jimenez RE, Z’Graggen K, Hartwig W, Graeme-Cook F, Warshaw AL, Fernandez-del Castillo C: Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats. Am J Pathol 1999;154:1223–1229.

    External Resources

  16. Z’Graggen K, Jimenez R, Werner J, Graeme-Cook F, Warshaw A, Fernandez-del Castillo C: Mutations of the K-ras but not the H-ras gene are involved in the carcinogenesis of DMBA-induced ductal pancreatic adenocarcinomas in rats. Pancreas 1998;17:460.
  17. Hotz HG, Hines OJ, Foitzik T, Reber HA: Animal models of exocrine pancreatic cancer. Int J Colorectal Dis 2000;15:136–143.

    External Resources

  18. Hall PA, Lemoine NR: Models of pancreatic cancer. Cancer Surv 1993;16:135–155.
  19. Caygill CP, Hill MJ, Hall CN, Kirkham JS, Northfield TC: Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer. Gut 1987;28:924–928.

    External Resources

  20. Taylor PR, Dowling RH, Palmer TJ, Hanley DC, Murphy GM, Mason RC, McColl I: Induction of pancreatic tumours by longterm duodenogastric reflux. Gut 1989;30:1596–1600.

    External Resources

  21. Gasslander T, Axelson J, Kakanson R, Ihse I, Lilja I, Rehfeld JF: Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats. Scand J Gastroenterol 1990;25:1060–1065.
  22. Chu M, Franzen L, Sullivan S, Rehfeld JF, Ihse I, Borch K: Effects of pancreaticobiliary diversion and gastric fundectomy on azaserine-induced pancreatic carcinogenesis in the rat. Pancreas 1993;8:330–337.
  23. Denda A, Inui S, Sunagawa M, Takahashi S, Konishi Y: Enhancing effect of partial pancreatectomy and ethionine-induced pancreatic regeneration on the tumorigenesis of azaserine in rats. Gann 1978;69:633–639.

    External Resources

  24. Pour P, Kruger FW, Althoff J, Cardesa A, Mohr U: Cancer of the pancreas induced in the Syrian golden hamster. Am J Pathol 1974;76:349–358.

    External Resources

  25. Pour PM, Stepan K: Carcinogenicity of N-nitrosobis(2-hydroxypropyl) amine after administration to Syrian hamster skin. Cancer Lett 1985;27:305–308.

    External Resources

  26. Pour PM: Experimental pancreatic cancer. Am J Surg Pathol 1989;13:96–103.

    External Resources

  27. van Kranen HJ, Vermeulen E, Schoren L, Bax J, Woutersen RA, van Iersel P, van Kreijl CF, Scherer E: Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. Carcinogenesis 1991;12:1477–1482.

    External Resources

  28. Schmied B, Liu G, Moyer MP, Hernberg IS, Sanger W, Batra S, Pour PM: Induction of adenocarcinoma from hamster pancreatic islet cells treated with N-nitrosobis(2-oxopropyl) amine in vitro. Carcinogenesis 1999;20:317–324.
  29. Pour PM: Histogenesis of exocrine pancreatic cancer in the hamster model. Environ Health Perspect 1984;56:229–243.

    External Resources

  30. Pour PM, Patil K: Modification of pancreatic carcinogenesis in the hamster model. X. Effect of streptozotocin. J Natl Cancer Inst 1983;71:1059–1065.

    External Resources

  31. Bell RH Jr, Pour PM: Pancreatic carcinogenicity of N-nitrosobis(2-oxopropyl)-amine in diabetic and non-diabetic Chinese hamster. Cancer Lett 1987;34:221–230.
  32. Pour PM, Kazakoff K: Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model. Am J Pathol 1996;149:1017–1025.
  33. Kazakoff K, Cardesa T, Liu J, Adrian TE, Bagchi D, Bagchi M, Birt DF, Pour PM: Effects of voluntary physical exercise on high-fat diet-promoted pancreatic carcinogenesis in the hamster model. Nutr Cancer 1996;26:265–279.

    External Resources

  34. Ishikawa O, Ohigashi H, Imaoka S, Nakai I, Mitsuo M, Weide L, Pour PM: The role of pancreatic islets in experimental pancreatic carcinogenicity. Am J Pathol 1995;147:1456–1464.

    External Resources

  35. Schneider M, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding X, Adrian T, Pour P: Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology, in press.
  36. Cersosimo E, Pisters P, Pesola G, McDermott K, Bajorunas D, Brennan M: Insulin secretion and action in patients with pancreatic cancer. Cancer 1991;67:476–493.
  37. Permert H, Herrington M, Kazakoff K, Pour PM, Adrian TE: Early changes in islet hormone secretion in the hamster pancreatic cancer model. Teratog Carcinog Mutagen 2001;21:59–67.
  38. Ahren B, Andren-Sandberg A: Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster. Res Exp Med (Berl) 1993;193:21–26.
  39. Schmied BM, Liu G, Matsuzaki H, Ulrich A, Hernberg S, Moyer MP, Weide L, Murphy L, Batra SK, Pour PM: Differentiation of islet cells in long-term culture. Pancreas 2000;20:337–347.
  40. Kerr-Conte J, Pattou F, Lecomte-Houcke M, Xia Y, Boilly B, Proye C, Lefebvre J: Ductal cyst formation in collagen-embedded adult human islet preparations: A means to the reproduction of nesidioblastosis in vitro. Diabetes 1996;45:1108–1114.
  41. Bouwens L, Lu WG, De Krijger R: Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 1997;40:398–404.
  42. Schmied B, Ulrich A, Matsuzaki H, Ding X, Ricordi C, Weide L, Moyer M, Batra S, Adrian T, Pour P: Transdifferentiation of human islets in long-term culture. Pancreas, in press.
  43. Takahashi M, Pour P, Althoff J, Donnelly T: Sequential alteration of the pancreas during carcinogenesis in Syrian hamsters by N-nitrosobis-(2-oxopropyl)amine. Cancer Res 1977;37:4602–4607.

    External Resources

  44. Issenberg P, Conrad EE, Nielsen JW, Klein DA, Miller SE: Determination of N-nitrosobis(2-hydroxyproyl)amine in environmental samples. IARC Sci Publ 1984;57:43–50.
  45. Brown JL: N-nitrosamines. Occup Med 1999;14:839–848.

    External Resources

  46. Hecht SS: Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proc Soc Exp Biol Med 1997;216:181–191.

    External Resources

  47. Tolbert PE: Oils and cancer. Cancer Causes Control 1997;8:386–405.

    External Resources

  48. Pour PM, Runge RG, Birl D, Gingell R, Lawson T, Nagel D, Wallcave L, Salmasi SZ: Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer 1981;47:1573–1589.

    External Resources

  49. Kolar C, Lawson T: Mutagenicity of carcinogenic nitrosamines when activated by hamster and human pancreatic duct epithelial cells. Cancer Lett 1997;117:149–154.

    External Resources

  50. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, Schwartz AG, Brown LM, Greenberg RS, Schoenberg JB, Pottern LM, Hoover RN, Fraumeni JF Jr: Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830–1837.
  51. Birt DF, Pelling JC, Pour PM, Tibbels MG, Schweickert L, Bresnick E: Enhanced pancreatic and skin tumorigenesis in cabbage-fed hamster and mice. Carcinogenesis 1987;8:913–917.

    External Resources

  52. Birt DF, Davies MH, Pour FM, Salmasi S: Lack of inhibition by retinoids of bis(2-oxopropyl)nitrosamine-induced carcinogenesis in Syrian hamsters. Carcinogenesis 1983;4:1215–1220.

    External Resources

  53. Birt DF, Julius AD, Runice CE, White LT, Lawson T, Pour PM: Enhancement of BOP-induced pancreatic conditions. Nutr Cancer 1988;11:21–33.

    External Resources

  54. Pour PM, Lawson T, Donnelly T, Stepan K: Modification of pancreatic carcinogenesis in the hamster model. XI. Inhibitory effect of pilocarpine hydrochloride. J Natl Cancer Inst 1984;72:191–194.

    External Resources

  55. Pour PM, Donnelly K, Stephan K: Modification of pancreatic carcinogenesis in the hamster model. III. Inhibitory effect of alloxan. Am J Pathol 1983;110:310–314.

    External Resources

  56. Pour PM, Lawson T: Modification of pancreatic carcinogenesis in the hamster model. XV. Preventive effect of nicotinamide. J Natl Cancer Inst 1984;73:767–770.

    External Resources

  57. Pour PM, Donnelly T, Stepan K: Modification of pancreatic carcinogenesis in the hamster model. VII. Inhibitory effect of bethanechol chloride. Am J Pathol 1983;112:178–184.

    External Resources

  58. Pour PM, Stepan K: Modification of pancreatic carcinogenesis in the hamster model. VIII. Inhibitory effect of exogenous insulin. J Natl Cancer Inst 1984;72:1205–1208.

    External Resources

  59. Pour PM, Reber HA, Stepan K: Modification of pancreatic carcinogenesis in the hamster model. XIII. Dose-related effect of ethanol. J Natl Cancer Inst 1983;71:1085–1087.

    External Resources

  60. Pour PM, Donnelly T, Stepan K, Muffy K: Modification of pancreatic carcinogenesis in the hamster model. II. The effect of partial pancreatectomy. Am J Pathol 1983;110:75–82.

    External Resources

  61. Gurskii T: On the problem of the experimental induction of pancreatic tumors. Probl Oncol 1959;5:97.
  62. Roebuck BD, Longnecker DS: Species and rat strain variation in pancreatic nodule induction by azaserine. J Natl Cancer Inst 1977;59:1273–1277.

    External Resources

  63. Zimmerman JA, Trombetta LD, Carter TH, Weisbroth SH: Pancreatic carcinoma induced by N-methyl-N′-nitrosourea in aged mice. Gerontology 1982;28:114–120.

    External Resources

  64. Rao MS, Subbarao V, Scarpelli DG: Atypical acinar cell lesions of the pancreas in mice induced by 4-hydroxyaminoquinoline-1-oxide. Int J Pancreatol 1987;2:1–10.

    External Resources

  65. Schmied BM, Ulrich AB, Matsuzaki H, El-Metwally TH, Ding X, Fernandes ME, Adrian TE, Chaney WG, Batra SK, Pour PM: Biologic instability of pancreatic cancer xenografts in the nude mouse. Carcinogenesis 2000;21:1121–1127.
  66. Shi Q, Xie K: Experimental animal models of pancreatic cancer. Int J Oncol 2000;17:217–225.

    External Resources

  67. Garofalo A, Chirivi RG, Scanziani E, Mayo JG, Vecchi A, Giavazzi R: Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice. Invasion Metastasis 1993;13:82–91.
  68. Hotz H, Hines O, Cortina G, Foitzik T, Buhr H, Reber H: Clinical nude mouse model of pancreatic cancer. A novel atraumatic technique for orthotopic implantation of tumor xenografts. Pancreas 1998;17:439.
  69. Lacaine F, Petroni R: Experimental models of pancreatic cancer; in Neoptolemos J, Lemoine N (eds): Pancreatic Cancer: Molecular and Clinical Advances. Oxford, Blackwell, 1996, pp 105–112.
  70. Jaenisch R: Transgenic animals. Science 1988;240:1468–1474.
  71. Hager JH, Hanahan D: Tumor cells utilize multiple pathways to down-modulate apoptosis: Lessons from a mouse model of islet cell carcinogenesis. Ann NY Acad Sci 1999;887:150–163.

    External Resources

  72. Hanahan D: Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985;315:115–122.
  73. Quaife CJ, Pinkert CA, Ornitz DM, Palmiter RD, Brinster RL: Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 1987;48:1023–1034.

    External Resources

  74. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC: Overexpression of TGF alpha in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990;61:1121–1135.
  75. Sandgren EP, Luetteke NC, Qui TH, Palmiter RD, Brinster RL, Lee DC: Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993;13:320–330.

    External Resources

  76. Greten F, Wagner M, Koschnik S, Weber C, Deppert W, Kern H, Adler G, Schmidt R: Cooperative effect of TGF-alpha and loss of p53 in pancreatic carcinoma susceptibility in vivo – role of type D-cyclins and INK proteins. Pancreas 1999;19:422.
  77. Yoshida T, Hanahan D: Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans. Am J Pathol 1994;145:671–684.

    External Resources

  78. Druckrey h, Ivankovic S, Bucheler J, Pressmann R, Thomas C: Production of stomach and pancreatic cancer in the guinea pig using methylnitroso-urea and methylnitroso-urethane. Z Krebsforsch 1968;71:167–182.

    External Resources

  79. Rao MS, Reddy JK: Pathology of tumors developed in guinea pigs given intraperitoneal injections of N-methyl-N-nitrosourea. Neoplasma 1977;24:57–62.

    External Resources

  80. Reddy JK, Svoboda DJ, Rao MS: Susceptibility of an ibred strain of guinea pigs to the induction of pancreatic adenocarcinoma by N-methyl-N-nitrosourea. J Natl Cancer Inst 1974;52:991–993.

    External Resources

  81. Kirev T, Woutersen RA, Kiril A: Effects of long term feeding of raw soya bean flour on virus-induced pancreatic carcinogenesis in guinea fowl. Cancer Lett 1999;135:195–202.

    External Resources

  82. O’Leary JF, Borner JW, Runge WJ, Dehner LP, Goodale RL: Hyperplasia of pancreatic duct epithelium produced by exposure to sodium deoxycholate. Am J Surg 1984;147:72–77.

    External Resources

  83. Kamano T, Tamura J, Uchida T, Kanno T, Sakakibara N, Tsutsumi M, Maruyama H, Konishi Y: Studies by pancreatography of ductal changes induced by administration of pancreatic carcinogen in two dogs. Jpn J Clin Oncol 1991;21:282–286.
  84. Kamano T, Azuma N, Katami A, Tamura J, Sakakibara N, Matsumoto M, Mizumoto K, Kitazawa S, Konishi Y: Preliminary observation on pancreatic duct adenocarcinoma induced by intraductal administration of N-ethyl-N′-nitro-N-nitrosoguanidine in dogs. Jpn J Cancer Res 1988;79:1–4.

    External Resources

  85. Sato T: Experimental study of pancreatic duct adenocarcinoma in dog (in Japanese). Nippon Geka Gakkai Zasshi 1991;92:1486–1492.
  86. Kamano T, Mori Y, Suda K, Takahashi M, Uchida T, Takada T, Tsutsumi M, Konishi Y: Mutagenic activation of N-ntitrosobis(2-oxopropyl)amine by pancreatic juice and assessment of its ductal tumorigenicity following intraductal administration in dogs. Int J Pancreatol 1996;20:51–57.

    External Resources

  87. Elkort RJ, Handler AH, Mozden PJ: Preneoplastic changes in rabbit pancreatic duct cells produced by dimethylhydrazine. Int J Cancer 1975;16:810–818.

    External Resources

  88. Nakase A, Koizumi T, Fujita N, Ono H, Matsumoto Y: Studies of the growth and infiltration of experimental tumor of the pancreas in rabbits. Am J Surg 1977;133:590–592.

    External Resources

  89. Nagakawa T, Kayahara M, Ohta T, Ueno K, Konishi I, Miyazaki I: Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer (see comments). Int J Pancreatol 1991;10:113–119.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50